BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22592763)

  • 21. Nocturnal gastroesophageal reflux disease: issues, implications, and management strategies.
    Johnson DA; Katz PO
    Rev Gastroenterol Disord; 2008; 8(2):98-108. PubMed ID: 18641592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of antireflux treatment on the frequency of awakenings from sleep in patients with Gastroesophageal reflux disease.
    Jha LK; Maradey-Romero C; Gadam R; Hershcovici T; Fass OZ; Quan SF; Guillen J; Fass R
    Neurogastroenterol Motil; 2015 Feb; 27(2):237-45. PubMed ID: 25484104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroesophageal reflux disease as an etiology of sleep disturbance in subjects with insomnia and minimal reflux symptoms: a pilot study of prevalence and response to therapy.
    Shaheen NJ; Madanick RD; Alattar M; Morgan DR; Davis PH; Galanko JA; Spacek MB; Vaughn BV
    Dig Dis Sci; 2008 Jun; 53(6):1493-9. PubMed ID: 17985241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sorting out the Relationship between Gastroesophageal Reflux Disease and Sleep.
    Kurin M; Shibli F; Kitayama Y; Kim Y; Fass R
    Curr Gastroenterol Rep; 2021 Aug; 23(9):15. PubMed ID: 34338891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep disturbance and enhanced esophageal capsaicin sensitivity in patients with gastroesophageal reflux disease.
    Yi CH; Lei WY; Hung JS; Liu TT; Orr WC; Chen CL
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1940-1945. PubMed ID: 27131333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of treatment pattern and symptom control in patients with gastroesophageal reflux disease: multihospital questionnaire survey on the current situation in Korea.
    Seo SI; Bang CS; Kang HS; Choi MH; Shin WG; Jang HJ; Kim JB; Baik KH; Kae SH; Kim HY
    Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep dysfunction in Japanese patients with gastroesophageal reflux disease: prevalence, risk factors, and efficacy of rabeprazole.
    Fujiwara Y; Kohata Y; Kaji M; Nebiki H; Yamasaki T; Sasaki E; Hayakawa T; Machida H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    Digestion; 2010; 81(3):135-41. PubMed ID: 20090330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evaluation of recumbent reflux by multichannel intraluminal impedance pH testing for patients with gastroesophageal reflux disease and sleep disturbance.
    Hoshino M; Omura N; Yano F; Tsuboi K; Yamamoto SR; Akimoto S; Masuda T; Kashiwagi H; Yanaga K
    Esophagus; 2020 Jul; 17(3):348-354. PubMed ID: 31970574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of sleep disturbance to the integrity and characteristics of secondary peristalsis in patients with gastroesophageal reflux disease.
    Yi CH; Lei WY; Hung JS; Liu TT; Orr WC; Chen CL
    Scand J Gastroenterol; 2017 Feb; 52(2):136-142. PubMed ID: 27608729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships between sleep disturbances and gastroesophageal reflux disease in Asian sleep clinic referrals.
    Ju G; Yoon IY; Lee SD; Kim N
    J Psychosom Res; 2013 Dec; 75(6):551-5. PubMed ID: 24290045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications.
    Jung HK; Choung RS; Talley NJ
    J Neurogastroenterol Motil; 2010 Jan; 16(1):22-9. PubMed ID: 20535322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroesophageal Reflux Disease: A Review.
    Maret-Ouda J; Markar SR; Lagergren J
    JAMA; 2020 Dec; 324(24):2536-2547. PubMed ID: 33351048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD.
    Fass R; Johnson DA; Orr WC; Han C; Mody R; Stern KN; Pilmer BL; Perez MC
    Am J Gastroenterol; 2011 Mar; 106(3):421-31. PubMed ID: 21224838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment.
    Spechler SJ
    Gastroenterol Clin North Am; 2020 Sep; 49(3):437-450. PubMed ID: 32718563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approach to gastroesophageal reflux disease in primary care: Putting the Montreal definition into practice.
    Flook N; Jones R; Vakil N
    Can Fam Physician; 2008 May; 54(5):701-5. PubMed ID: 18474703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esophageal reflux disease proton pump inhibitor therapy impact on sleep disturbance: a systematic review.
    Regenbogen E; Helkin A; Georgopoulos R; Vasu T; Shroyer AL
    Otolaryngol Head Neck Surg; 2012 Apr; 146(4):524-32. PubMed ID: 22307577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and psychosocial impact of different reflux time in gastroesophageal reflux disease patients.
    Chen JH; Wen SH; Hsu CS; Yi CH; Liu TT; Chen CL; Wang CC
    J Formos Med Assoc; 2017 Feb; 116(2):123-128. PubMed ID: 27133182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations among gastroesophageal reflux disease, psychological stress, and sleep disturbances in Japanese adults.
    Okuyama M; Takaishi O; Nakahara K; Iwakura N; Hasegawa T; Oyama M; Inoue A; Ishizu H; Satoh H; Fujiwara Y
    Scand J Gastroenterol; 2017 Jan; 52(1):44-49. PubMed ID: 27571846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.